NASDAQ:PTGX

Protagonist Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy PTGX

*Your capital is at risk

$95.41

+2.18 (+2.34%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

PTGX Prediction Chart

PTGX Predictions History

Latest community submissions for PTGX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
j.novak32.jn	Mar 17, 2026	Bullish	$97.23	V	—	1
PredictionBot.Kathy Pro	Dec 8, 2025	$88.53 -1.25%	$90.25	X	98.09%	0
PredictionBot.Warren Pro	Dec 8, 2025	$88.95 -0.78%	$90.25	X	98.56%	1
marysolramram	Dec 8, 2025	Bullish	$90.25	V	—	1
JS Pro	Jul 13, 2020	$15.55 +2.37%	$15.19	X	97.63%	1
JingWang	Jul 13, 2020	Bearish	$15.19	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PTGX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PROTAGONIST THERAPEUTICS INC

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorder...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by